Table 2.
Overview of the reimbursement of fertility-preserving measures for men in Germany, Austria, and Switzerland
| Criteria | Germany | Austria | Switzerland |
|---|---|---|---|
| Reimbursement of fertility preservation before cancer therapy | Yes | No | Yes |
| Lower age limit | From puberty | IVF Fund: from 18 years | Post-pubertal |
| Upper age limit | Up to 50 years | IVF Fund: up to 50 years | Up to 40 years |
| Criteria | Benign and malignant diseases that may lead to fertility impairment | Partnership, indication, health insurance, main residence of one partner, age limits, citizenship (or residence permit) | Malignant and benign diseases requiring chemo- or radiotherapy, with a risk of azoospermia > 20% |
| Techniques |
Cryopreservation of sperm Biopsies and cryopreservation of testicular tissue Storage up to the 50th year of age |
– |
Cryopreservation of sperm Removal and cryopreservation of testicular tissue Storage up to 10 years |
| Reimbursement of GnRH analogues | No | – | No |
| Sufficient cost coverage of measures | No | No | Yes |
| Reimbursement of fertility preservation after cancer therapy | No (possibly case-by-case decision) | No | No |